Fever



Fever


Katharine F. Lunn


Fever is a common clinical finding in patients with infectious, parasitic, inflammatory, immune-mediated, or neoplastic disease. In many of these patients, fever is accompanied by other more specific or localizing clinical signs, and the cause of the fever is determined with simple diagnostic tests. In some cases, the cause of the fever is not readily apparent, but it resolves spontaneously or in response to empiric therapy, often with antibacterials. In a small subset of patients, the cause of fever is not easily determined and not therapeutically responsive, and the problem becomes persistent or recurrent. Such cases of fever of unknown origin (FUO) present a particular diagnostic challenge in both human and veterinary medicine.3,24,34,35,57 This chapter outlines the pathophysiology of fever and presents an approach to the small animal patient with FUO.



Pathophysiology of Fever


Body temperature is determined by the set-point of the hypothalamic thermoregulatory center. Thermoregulation depends on sensory information from external and internal thermoreceptors and on physiologic and behavioral effector mechanisms that control heat production and heat loss. Body heat is lost through the skin and the respiratory tract and can be gained by transfer from the environment or generated by muscle activity or body fat catabolism. Body temperature is decreased by panting, cutaneous vasodilation, seeking shelter, and remaining inactive (Fig. 95-1, A). In a cold environment, body temperature is maintained by shivering, postural changes, piloerection, and cutaneous vasoconstriction (see Fig. 95-1, B). In a normal animal, these mechanisms balance heat loss and heat gain and keep the body temperature as close as possible to the normal hypothalamic set-point (Fig. 95-2, A).




Hyperthermia refers to any increase in body temperature above normal. In true fever, the hypothalamic set-point is elevated, and body temperature is increased by enhanced heat production and conservation. Heat gain and heat loss mechanisms now act to maintain body temperature at the new set-point (see Fig. 95-2, B). In nonfebrile hyperthermic conditions, the hypothalamic set-point is not altered, and elevated body temperature is the result of increased and unregulated heat gain or heat production or impaired heat loss (see Fig. 95-2, C). Examples of nonfebrile causes of hyperthermia include heat stroke, exercise-induced hyperthermia, malignant hyperthermia, seizure activity, and hypermetabolic disorders. Hyperthermia of this type can progress to multiorgan-dysfunction syndrome caused by an interplay among circulatory disturbances, hypoxia, increased metabolic demand, cytotoxicity of high temperature, and activation of inflammatory and coagulation cascades.11


Fever is mediated by the action of pyrogens. Exogenous pyrogens (infectious agents and their products, tumors, drugs, and toxins) stimulate inflammatory cells to release endogenous pyrogens (cytokines such as interferons, interleukin [IL]-1β and -6, and tumor necrosis factor [TNF]-α), and this leads to induction of cyclooxygenase 2 activation of the arachidonic acid cascade, with enhanced synthesis of prostaglandin E2 (PGE2). PGE2 is synthesized by hypothalamic vascular endothelial cells and acts on thermoregulatory neurons to raise the hypothalamic set-point. The thermoregulatory set-point is located in a rich vascular network called the organum vasculosum laminae terminalis in the preoptic rostral hypothalamus that possesses little if any blood-brain barrier. Endothelial cells within this area are thought to release arachidonic metabolites themselves, and then metabolites of cyclooxygenase such as PGE2 are thought to diffuse the short distance to the hypothalamic neurons and induce fever. PGE2, which itself is not neurally active, can induce production of cAMP or other neurotransmitters, which, in turn, raises the temperature set-point of the body. Additional evidence suggests that the thermoregulatory center may also be stimulated via vagal fibers that respond to release of cytokines locally released in tissues.71 The pathogenesis of fever is summarized in Fig. 95-3.




Fever of Unknown Origin


FUO in both human and veterinary medicine can be most usefully defined as fever that does not resolve spontaneously in the period expected for self-limited infection and the cause of which cannot be ascertained despite considerable diagnostic effort.3 In veterinary medicine, this diagnostic effort typically includes a complete history and physical examination, complete blood (cell) count (CBC), chemistry, urinalysis, and radiography. It is also common for veterinary patients to receive antibacterial therapy to address possible bacterial infection before it is determined that the origin of the fever is unknown.



Etiology of Fever of Unknown Origin


Although fever is frequently associated with infectious diseases, the same response can be elicited by many inflammatory, immune, or neoplastic disorders. Because the list of differential causes for FUO is extensive, grouping these causes into broad categories based on the underlying disease process is useful. Table 95-1 shows the causes of FUO divided into infectious and parasitic diseases, Table 95-2 summarizes inflammatory and immune-mediated causes of FUO, and neoplastic and miscellaneous causes are listed in Table 95-3. In the human medical literature, the causes of FUO are typically distributed as follows: 30% to 40% are infectious, 20% to 30% are neoplastic, 10% to 20% are rheumatologic, 15% to 20% are miscellaneous, and 5% to 15% are undiagnosed. Broadly similar distributions have been reported in veterinary patients, but variation can be found among reported case series.57 This variation may be caused by both the particular clinical interests of the authors and their geographic locations. Published case series are also exclusively or predominantly canine.31,57 Infection, immune-mediated disease, and neoplasia are the most common causes of FUO in the dog, whereas FUO in cats appears most likely to be infectious in origin.34,51





Fever is rarely an isolated finding in these cases, given that IL-1β, TNF-α, and IL-6 induce a large number of complex immunopathologic events. These events contribute to the acute-phase response, which is a vital part of the innate immune system. Important acute-phase proteins include C-reactive protein, serum amyloid-A, haptoglobin, alpha-1-acid glycoprotein, ceruloplasmin, and fibrinogen. The former proteins are synthesized by the liver and are increased in the acute-phase response, whereas synthesis of other proteins such as albumin and transferrin is decreased. See pathophysiology of sepsis (Chapter 36) for a thorough review of many of these immunopathologic mechanisms.



Development of a Diagnostic Plan for Fever of Unknown Origin


Although some patients with FUO may have uncommon infectious, inflammatory, or neoplastic diseases, many patients are ultimately found to have an unusual or early manifestation of a common disorder.3 Therefore, the clinician must approach these cases in a systematic fashion that allows for the detection of any potential cause of fever while avoiding unnecessary testing and minimizing patient discomfort. A diagnostic plan for FUO may be based on consideration of the disease process, as outlined in Tables 95-1, 95-2, and 95-3. A complementary approach is summarized in Table 95-4, in which the causes of FUO are grouped according to anatomic or body system location. This approach is helpful in selecting diagnostic tests, particularly when localizing clinical signs are absent or subtle. By combining a disease process and anatomic approach, the clinician can develop a comprehensive diagnostic plan for any FUO patient.



TABLE 95-4


Causes of Fevers of Unknown Origin Grouped by Body System or Region




















































Body System or Region Appropriate Diagnostic Tests Examples
Blood and hematopoietic CBC, blood film evaluation, bone marrow aspirate, urinalysis, ophthalmic fundic exam, bone marrow biopsy, serum protein electrophoresis, FeLV and FIV tests, other serology, blood culture Leukemia, myeloma, bacteremia, drugs, ehrlichiosis, granulocytopathy, hypereosinophilic syndromes, hemotrophic mycoplasmosis, metastatic neoplasia, walled-off hematomas
Lymphoid Lymph node palpation, lymph node cytology and culture, lymph node biopsy, lymphangiography Lymphoma, lymphadenitis, lymphangitis
Cardiovascular Auscultation, radiography, angiography, electrocardiography, echocardiography, vascular biopsy, pericardiocentesis, blood culture Endocarditis, pericarditis, vasculitis
Respiratory Radiography, transtracheal or endotracheal wash, fine-needle aspiration, biopsy, ultrasonography, bronchoscopy, bronchoalveolar lavage, CT, thoracoscopy Bronchial foreign body, fungal or bacterial pneumonia, neoplasia, pulmonary embolism
Nervous system Fundic and neurological examination, radiography, myelography, CT, MRI, nerve or muscle biopsy, CSF analysis Toxoplasmosis, fungal infection, steroid-responsive meningitis-arteritis, FIP
Musculoskeletal Radiography, arthroscopy, blood culture, arthrocentesis, synovial membrane biopsy, bone biopsy, RF, ANA Immune-mediated polyarthritis, myositis, panosteitis, diskospondylitis
Gastrointestinal Radiography, barium contrast studies, ultrasonography, rectal examination, fecal cytology, rectal cytology, fecal culture, oral and dental radiographs, pancreatic lipase immunoreactivity, trypsin-like immunoreactivity, endoscopy, laparoscopy, exploratory surgery, biopsy Neoplasia or abscess anywhere in GI tract, pancreatitis, inflammatory bowel disease, fungal disease, portosystemic shunt, hepatobiliary, gastric, or splenic inflammation
Urogenital Urinalysis, urine culture, prostatic wash and ejaculate cytology and culture, radiography, ultrasonography, IV pyelography, cystography, cystoscopy, vaginoscopy, cytology, biopsy Prostatitis, stump pyometra, pyelonephritis, orchitis
Endocrine Biochemical profile, thyroid hormone Hyperthyroidism
Pleural or peritoneal cavity Radiography, ultrasonography, fluid analysis, cytology, microbial culture, biopsy Pyothorax, FIP, peritonitis, neoplasia
Skin Physical examination, cytology, biopsy, microbial culture, fistulography Abscess, fungal infection, nodular panniculitis, vasculitis, actinomycosis, nocardiosis, mycobacteriosis

ANA, Antinuclear antibody; CBC, complete blood cell count; CSF, cerebrospinal fluid; CT, computed tomography; FeLV, feline leukemia virus; FIP, feline infectious peritonitis; FIV, feline immunodeficiency virus; GI, gastrointestinal; IV, intravenous; MRI, magnetic resonance imaging; RF, rheumatoid factor. Table adapted, with permission, from Ref. 57.


In addition to including appropriate diagnostic tests, the diagnostic plan should follow a sequence that is both logical and flexible. The typical diagnostic plan will begin with tests that are safe, simple, inexpensive, and easy to interpret. A staged approach can be used to guide the selection of diagnostic tests, and examples are outlined in Box 95-1.



BOX 95-1


Staged Approach to the Diagnostic Evaluation of the Patient with Fever of Unknown Origina






aFever is not harmful. Many diagnostic tests are needed and may have to be repeated or these lists recycled. Tests recommended in each staging column are listed in increasing order of expense or risk to animal. These tests are not indicated for initial work-up and may be considered appropriate with successive work-ups. With persistence, a diagnosis is often made and there is a favorable response to treatment. Box adapted, with permission, from Ref. 57.


ANA, Antinuclear antibody; CBC, complete blood cell count; FeLV, feline leukemia virus; FIV, feline immunodeficiency virus.


The results of stage 1 tests in the FUO patient will determine the tests to be performed at the next stage. If the fever has not been localized, more specialized procedures can also be introduced. Stages 2 and 3 require the repetition of earlier tests and introduce the need for advanced imaging and more invasive procedures. Ideally, the selection of the tests used in stage 3 will be based on abnormalities detected in stages 1 and 2.


An important aspect of staged testing in the FUO patient is the need to repeat the early, less invasive, and less expensive tests frequently enough to detect new changes. The key is not to rigidly follow a predetermined and fixed diagnostic plan but rather to review and modify the plan as new results become available. For example, if repeated CBCs demonstrate developing pancytopenia, a bone marrow aspirate and biopsy should be performed early in the diagnostic plan and not reserved for stage 3.



Client Communication


The management of the FUO patient demands flexibility, dedication, and patience from both the clinician and the client. By definition, patients with FUO will already have undergone several basic diagnostic tests, and some may have received one or more courses of antibacterial therapy. Clients may be frustrated by the failure to reach a diagnosis or the continuation of the patient’s clinical signs. Good client communication is vital to the successful resolution of the FUO case. The clinician should explain that many diagnostic tests, including repeated tests, may be necessary to reach a diagnosis and that the process can be time consuming and expensive. However, clients should also be reassured that a diagnosis is reached in most cases, that many causes of FUO may be treatable or even curable, and that the fever itself is rarely harmful to the patient.



History


The patient history should include details of geographic location and environment, travel history, lifestyle (e.g., indoor versus outdoor, history of hunting), and exposure to ticks or other vectors. All of these factors will influence exposure to specific microorganisms. The medical history should cover diet, vaccination, heartworm and other parasite treatment and prevention, the administration of any other medications, and previous medical or surgical problems. The response to past therapies used for the fever problem should be noted. Clients should be questioned about the patient’s urination and defecation habits and the presence of clinical signs such as lameness; neck, back, or abdominal pain; skin lesions; masses or swellings; weakness; exercise intolerance; coughing; nasal discharge; and dyspnea.

Stay updated, free articles. Join our Telegram channel

Aug 6, 2016 | Posted by in INTERNAL MEDICINE | Comments Off on Fever

Full access? Get Clinical Tree

Get Clinical Tree app for offline access